RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Multiple Myeloma Research Foundation
M

Multiple Myeloma Research Foundation portfolio

Multiple Myeloma Research Foundation has 1 portfolio company on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $45M.
Latest deal: Triumvira Immunologics · Mar 17, 2022.
About this page

Its most recent investment on record is Triumvira Immunologics's $45M Series A round in March 2022, alongside ATEM Capital Fund LP, Leaps by Bayer, Myeloma Investment Fund and 2 others. That company is in Health and bio.

What Multiple Myeloma Research Foundation invests in

How Multiple Myeloma Research Foundation invests

StageDealsCapital in rounds
Series A 1 100%$45M

Multiple Myeloma Research Foundation portfolio companies

CompanyRound with Multiple Myeloma Research FoundationTotal raisedLatest raise
TTriumvira Immunologics
Health and bio
Series A · $45M$100MMar 17, 2022
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name Multiple Myeloma Research Foundation. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Multiple Myeloma Research Foundation, which is a subset of its real portfolio. API: /api/v1/investors/multiple-myeloma-research-foundation (get a free API key). More: the most active VC firms and new venture capital funds.